{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T18:43:02Z","timestamp":1747161782742,"version":"3.40.5"},"reference-count":11,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","heartrhythmjournal.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Rhythm"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.hrthm.2024.07.101","type":"journal-article","created":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T15:46:53Z","timestamp":1722008813000},"page":"2458-2459","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Do non-dihydropyridine calcium channel blockers increase bleeding risk with direct oral anticoagulants?"],"prefix":"10.1016","volume":"21","author":[{"given":"Peter","family":"Calvert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7566-1626","authenticated-orcid":false,"given":"Gregory Y.H.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.hrthm.2024.07.101_bib1","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1111\/bcp.12541","article-title":"Effect of ketoconazole and diltiazem on the pharmacokinetics of apixaban, an oral direct factor Xa inhibitor","volume":"79","author":"Frost","year":"2015","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.hrthm.2024.07.101_bib2","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1016\/j.hrthm.2024.06.040","article-title":"Diltiazem, direct oral anticoagulants and risk of major bleeding in patients with atrial fibrillation","volume":"21","author":"Ang","year":"2024","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2024.07.101_bib3","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1016\/j.hrthm.2024.06.033","article-title":"Potential interactions between medications for rate control and direct oral anticoagulants: population-based cohort and case-crossover study","volume":"21","author":"Wong","year":"2024","journal-title":"Heart Rhythm"},{"author":"Winijkul","key":"10.1016\/j.hrthm.2024.07.101_bib4"},{"key":"10.1016\/j.hrthm.2024.07.101_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.912618","article-title":"Why we need to take a closer look at genetic contributions to CYP3A activity","volume":"13","author":"Zhai","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.hrthm.2024.07.101_bib6","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.3593","article-title":"Association of oral anticoagulants and verapamil or diltiazem with adverse bleeding events in patients with nonvalvular atrial fibrillation and normal kidney function","volume":"3","author":"Pham","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.hrthm.2024.07.101_bib7","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1001\/jama.2024.3867","article-title":"Serious bleeding in patients with atrial fibrillation using diltiazem with apixaban or rivaroxaban","volume":"331","author":"Ray","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.hrthm.2024.07.101_bib8","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1016\/j.hrthm.2024.06.038","article-title":"Time to benefit and harm of direct oral anticoagulants in device-detected atrial fibrillation: a pooled analysis of the NOAH-AFNET 6 and ARTESiA trials","volume":"21","author":"Huang","year":"2024","journal-title":"Heart Rhythm"},{"author":"Kang","key":"10.1016\/j.hrthm.2024.07.101_bib9"},{"key":"10.1016\/j.hrthm.2024.07.101_bib10","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1055\/s-0042-1760365","article-title":"Bleeding risk in elderly patients with venous thromboembolism who would have been excluded from anticoagulation trials","volume":"123","author":"Schenker","year":"2023","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.hrthm.2024.07.101_bib11","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1055\/s-0042-1750385","article-title":"Assessment and mitigation of bleeding risk in atrial fibrillation and venous thromboembolism: executive summary of a European and Asia-Pacific expert consensus paper","volume":"122","author":"Gorog","year":"2022","journal-title":"Thromb Haemost"}],"container-title":["Heart Rhythm"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527124030789?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527124030789?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T10:12:00Z","timestamp":1732702320000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1547527124030789"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":11,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S1547527124030789"],"URL":"https:\/\/doi.org\/10.1016\/j.hrthm.2024.07.101","relation":{},"ISSN":["1547-5271"],"issn-type":[{"type":"print","value":"1547-5271"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Do non-dihydropyridine calcium channel blockers increase bleeding risk with direct oral anticoagulants?","name":"articletitle","label":"Article Title"},{"value":"Heart Rhythm","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hrthm.2024.07.101","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.hrthm.2024.06.038","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.hrthm.2024.06.040","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.hrthm.2024.06.033","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Heart Rhythm Society. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}